跳至主要内容
临床试验/ACTRN12616000381482
ACTRN12616000381482进行中(未招募)不适用

Effectiveness and cost effectiveness of Problem Management Plus (PM+) plus treatment as usual (TAU) vs. treatment as usual (TAU) in the management of common mental disorders in a tertiary mental health care facility in Pakistan: a single blind randomised controlled trial (RCT)

Human Development Research Foundation0 个研究点目标入组 192 人开始时间: 2016年3月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
192

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Clients of either gender will be included in the study, the age of participants from 18 to 60 years, GHQ score >2, and WHO DAS score > 16. GHQ-12 is the most extensively used screening instrument for common mental disorders, in addition to being a more general measure of psychiatric well-being, whereas, WHO DAS is a generic assessment instrument assessing health and disability.

排除标准

  • clients with severe mental disorder (for example, mania, seizures, psychosis, alcohol or drug-use dependence) and imminent suicide risk (Assessed using formal suicide risk assessment based on a WHO measure). reports of acute distress in the past month and clients that are residing outside of the study area and unable to attend for regular weekly PM+ sessions.

研究者

相似试验